MELONI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 4.274
EU - Europa 3.314
AS - Asia 2.054
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
OC - Oceania 6
SA - Sud America 1
Totale 9.664
Nazione #
US - Stati Uniti d'America 4.241
CN - Cina 1.805
IE - Irlanda 1.046
UA - Ucraina 544
FI - Finlandia 431
IT - Italia 375
DE - Germania 355
SE - Svezia 257
SG - Singapore 183
GB - Regno Unito 144
FR - Francia 74
CA - Canada 32
BE - Belgio 27
JP - Giappone 24
CZ - Repubblica Ceca 15
IN - India 14
RU - Federazione Russa 10
AT - Austria 9
NL - Olanda 8
EU - Europa 7
IR - Iran 7
ES - Italia 6
AU - Australia 5
MU - Mauritius 5
TR - Turchia 5
VN - Vietnam 5
LV - Lettonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
GR - Grecia 2
PL - Polonia 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
KG - Kirghizistan 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 9.664
Città #
Dublin 1.041
Chandler 974
Jacksonville 655
Nanjing 483
Ashburn 346
Boardman 298
Beijing 220
Nanchang 177
Princeton 176
Helsinki 168
Lawrence 168
Wilmington 157
Shenyang 148
Hebei 142
Changsha 126
Jiaxing 126
Medford 125
Ann Arbor 110
Singapore 106
New York 97
Pavia 84
Shanghai 83
Tianjin 79
Hangzhou 72
Milan 71
Los Angeles 56
Woodbridge 48
Verona 39
Seattle 38
Washington 32
Norwalk 28
Brussels 26
Toronto 24
Tokyo 23
Houston 20
Kunming 19
Des Moines 16
Munich 16
Fairfield 13
Piscataway 13
Taizhou 11
Zhengzhou 11
Pune 10
Brno 9
London 9
Ningbo 9
Dallas 8
Falls Church 8
Jinan 8
Vienna 8
Auburn Hills 7
Berlin 7
Lucera 7
Tappahannock 7
Chicago 6
Ottawa 6
San Francisco 6
Bari 5
Brescia 5
Santander 5
Teplice 5
Trieste 5
Borås 4
Dearborn 4
Dong Ket 4
Florence 4
Fuzhou 4
Genoa 4
Guangzhou 4
Lanzhou 4
Redwood City 4
Santa Clara 4
Turin 4
Changchun 3
Falkenstein 3
Istanbul 3
Kemerovo 3
Laives 3
Padova 3
Rome 3
Torino 3
Zelo Buon Persico 3
Andover 2
Bergamo 2
Cambridge 2
Catania 2
Chaozhou 2
Chengdu 2
Collegno 2
Erice 2
Hefei 2
Kish 2
Leawood 2
Mariglianella 2
Naples 2
Napoli 2
Newcastle upon Tyne 2
Ostuni 2
Rho 2
Riga 2
Totale 6.912
Nome #
Fotoaferesi extracorporea nel trattamento del rigetto polmonare cronico: risultati clinici ed immunologici preliminari di una piccola coorte di pazienti sottoposti a trapianto di polmone. 121
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 95
Effetti clinici ed immunologici di un trattamento a lungo termine con azitromicina nella sindrome da bronchiolite obliterante dopo trapianto polmonare. 94
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 92
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 90
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 89
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 86
Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. 86
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 84
Valutazione longitudinale delle cellule treg cd4+cd25highc69- in una coorte di riceventi di trapianto polmonare (ltrs). Un'associazione con il rigetto cronico del trapianto. 82
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 80
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 79
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients 79
Incidence of de novo malignancies in lung transplant recipients in Italy: a sinle institution experience, 1991-2008. 77
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 76
Rischio di sviluppo di tumori de-novo dopo trapianto di polmone in Italia: esperienza dell'I.R.C.C.S. Policlinico "San Matteo" di Pavia, 1991-2008. 76
Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation 75
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 75
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 75
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 74
Specific Anti-CMV Reactivity in BAL: A Useful Tool 74
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 73
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 72
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipiets 72
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 72
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 72
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 71
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 71
Organ Allocation Waiting Time During Extracorporeal Bridge to Lung Transplant Affects Outcomes 71
Persistent human cosavirus infection in lung transplant recipient, Italy. 70
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 70
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 69
Regulatory T cells in kidney transplant recipients. 69
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 69
Minute pulmonary meningothelial-like nodules in the transbronchial biopsy of a lung transplant recipient 68
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 67
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 67
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome. 67
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 66
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 66
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 65
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 64
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 64
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 64
[Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. 63
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 63
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 63
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. 63
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 62
Interferong and Interleukin5 production by T helper cells in renal transplant recipients treated with sirolimus-based immunosuppression 62
Bombesin, calcium homeostasis and tumour growth 62
Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture. 62
Aortic valve replacement performed twice through ministernotomy 15 years after lung transplantation. 62
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 62
Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus 62
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 62
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 62
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 61
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 61
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 61
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 61
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 60
Seroprevalence of hepatitis B virus markers and risk factors in patients and staff of an Italian residential institution for the mentally disabled 59
Only genuine CD4+CD25+ Tregs may be friends or foes 59
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. 59
Idolamina 2,3-diaossigenasi nella tolleranza dell'allotrapianto di polmone. 59
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 59
Changes is Th1/Th2 balance in hemodialysis patients: effect of different membranes 59
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 59
Asymptomatic persistent pulmonary infiltrates in an immunocompetent boy with cat-scratch disease. 58
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 58
Possible Disease Markers in BAL Fluid of BOS Patients 58
Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages 58
Cerebrospinal fluid ferritin in human disease. 58
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 57
Solid Solutions of AB2C4 Defect Semiconductors 57
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 57
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome 57
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 57
An innovative cellular approach to BOS: targeted antibody-engineered gold nanoparticles and characterization of cells for new therapeutic treatment 57
Serum levels of interleukin12, interleukin 18 and interferon gamma in ischemic acute renal failure (ARF) 57
Tumor necrosis factor alpha. Biological aspects 56
Mechanisms of lung injury in cystic fibrosis. 56
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 56
Plasma levels and blood mononuclear cell release of IL-18 in patients on hemodialysis 56
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 56
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 56
Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection. 55
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 55
Epidemiological study on alcohol consumption trends and on the sffects of alcohol consumption on the human body. Note 2: levels of lead in red wine from a northern italian region 55
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 55
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 54
Pulmonary Cladophialophora boppii infection in a lung transplant recipient: case report and literature review. 53
Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. 53
Asymptomatic persistent pulmonary infiltrates in an immunocompetent boy with cat-scratch disease 53
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 53
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 53
Is contrast-enhanced US alternative ti spinal CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? 53
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 53
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 52
Totale 6.587
Categoria #
all - tutte 41.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020587 0 0 0 0 4 109 32 110 19 190 120 3
2020/20211.104 124 87 38 110 3 155 11 172 62 156 145 41
2021/2022747 32 5 18 13 21 19 20 40 47 23 118 391
2022/20232.850 295 207 15 252 293 275 1 163 1.231 21 64 33
2023/20241.308 147 210 60 80 137 344 43 79 8 102 34 64
2024/2025543 77 211 94 108 53 0 0 0 0 0 0 0
Totale 9.842